BCI-121
featured

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562274

CAS#: 432529-82-3

Description: BCI-121 is an SMYD3 inhibitor. It acts by impairing cancer cell growth.


Price and Availability

Size Price Shipping out time Quantity
5mg USD 230 2 Weeks
25mg USD 580 2 Weeks
1g USD 2950 2 Weeks
2g USD 5650 2 Weeks
5g USD 7650 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2020-10-19. Prices are subject to change without notice.

BCI-121, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 562274
Name: BCI-121
CAS#: 432529-82-3
Chemical Formula: C14H18BrN3O2
Exact Mass: 339.0582
Molecular Weight: 340.22
Elemental Analysis: C, 49.42; H, 5.33; Br, 23.49; N, 12.35; O, 9.41


Synonym: BCI-121; BCI 121; BCI121;

IUPAC/Chemical Name: 4-(Aminocarbonyl)-N-(4-bromophenyl)-1-piperidineacetamide

InChi Key: KSUYPIXCRPCPGF-UHFFFAOYSA-N

InChi Code: InChI=1S/C14H18BrN3O2/c15-11-1-3-12(4-2-11)17-13(19)9-18-7-5-10(6-8-18)14(16)20/h1-4,10H,5-9H2,(H2,16,20)(H,17,19)

SMILES Code: O=C(NC1=CC=C(Br)C=C1)CN2CCC(C(N)=O)CC2


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Huang L, Xu AM. SET and MYND domain containing protein 3 in cancer. Am J Transl Res. 2017 Jan 15;9(1):1-14. eCollection 2017. Review. PubMed PMID: 28123630; PubMed Central PMCID: PMC5250700.

2: Peserico A, Germani A, Sanese P, Barbosa AJ, Di Virgilio V, Fittipaldi R, Fabini E, Bertucci C, Varchi G, Moyer MP, Caretti G, Del Rio A, Simone C. A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth. J Cell Physiol. 2015 Oct;230(10):2447-2460. doi: 10.1002/jcp.24975. PubMed PMID: 25728514; PubMed Central PMCID: PMC4988495.